“Resistance to Pembrolizumab and Axitinib in Renal Cell Carcinoma: Clinical and Genomic Evaluation”. Journal of Kidney Cancer 7, no. 1 (June 2, 2020): 7–11. Accessed April 21, 2026. https://jkcvhl.com/~jkcvhlco/index.php/jkcvhl/article/view/135.